Who Paid My Doc
Atriclip Laa Exclusion System
Device Cardiovascular
PDI 10840143901386
General payments
$23,576,134
Research payments
$11,038,071
Through program year 2025, $23,576,134 in general payments and $11,038,071 in research payments were reported against Atriclip Laa Exclusion System (Cardiovascular).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $544,709 | 10,064 |
| 2025 | Research | $470,048 | 59 |
| 2024 | General | $553,191 | 6,378 |
| 2024 | Research | $7,355,510 | 427 |
| 2023 | General | $17,979,997 | 6,863 |
| 2023 | Research | $2,608,436 | 446 |
| 2022 | General | $2,898,353 | 4,814 |
| 2022 | Research | $604,076 | 206 |
| 2021 | General | $1,599,884 | 4,175 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 80 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
32,294 general · 1,138 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.